Successful conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (Myfortic®) in liver transplant patients with gastrointestinal side effects

被引:0
|
作者
Robaeys, G. [1 ]
Cassiman, D. [1 ]
Verslype, C. [1 ]
Monbaliu, D. [2 ]
Aerts, R. [2 ]
Pirenne, J. [2 ]
Nevens, F. [1 ]
机构
[1] KULeuven, Dept Hepatol, UZ Gasthuisberg, Leuven, Belgium
[2] KULeuven, Dept Abdominal Transplantat Surg, UZ Gasthuisberg, Leuven, Belgium
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
229
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 50 条
  • [1] Successful Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium (Myfortic) in Liver Transplant Patients With Gastrointestinal Side Effects
    Robaeys, G.
    Cassiman, D.
    Verslype, C.
    Monbaliu, D.
    Aerts, R.
    Pirenne, J.
    Nevens, F.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (02) : 610 - 613
  • [2] Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in Patients with Gastrointestinal Side Effects: Case Studies
    Anita Boswell
    Magdi Shehata
    [J]. Drugs, 2006, 66 (Suppl 2) : 19 - 22
  • [3] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in patients with gastrointestinal side effects:: Case studies
    Boswell, Anita
    Shehata, Magdi
    [J]. DRUGS, 2006, 66 : 19 - 22
  • [4] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
    Tuncer, Murat
    [J]. DRUGS, 2006, 66 : 9 - 10
  • [5] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
    Tuncer M.
    [J]. Drugs, 2006, 66 (Suppl 2) : 9 - 10
  • [6] Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients
    Toledo, Alexander H.
    Hendrix, Laura
    Buchholz, Valorie
    Fisher, Erin
    Newton, Kimberly
    Smith, Courtney
    Gerber, David A.
    [J]. CLINICAL TRANSPLANTATION, 2012, 26 (01) : 156 - 163
  • [7] Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: Conversion to enteric-coated mycophenolate sodium
    Calvo, N.
    Sanchez-Fructuoso, A. I.
    Conesa, J.
    Moreno, A.
    Barrientos, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2396 - 2397
  • [8] Switching From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients With Gastrointestinal Complications
    Barrera-Pulido, L.
    Alamo-Martinez, J. M.
    Marin-Gomez, L. M.
    Suarez-Artacho, G.
    Bernal-Bellido, C.
    Dominguez-Usero, D.
    Tallon-Aguilar, L.
    Pareja-Ciuro, F.
    Sousa-Martin, J. M.
    Garcia-Gonzalez, I.
    Gomez-Bravo, M. A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2192 - 2194
  • [9] Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil
    Lopez-Solis, Roberto
    DeVera, Michael
    Steel, Jennifer
    Fedorek, Sheila
    Sturdevant, Mark
    Hughes, Christopher
    Humar, Abhinav
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (07) : 783 - 788
  • [10] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study
    Dumortier, Jerome
    Gagnieu, Marie-Claude
    Salandre, Janine
    Guillaud, Olivier
    Guillem, Philipe
    Adham, Mustapha
    Boillot, Olivier
    [J]. LIVER TRANSPLANTATION, 2006, 12 (09) : 1342 - 1346